Rok Su Shim, Fahad Hassan Shah, Young Seok Eom, Saad Salman, Song Ja Kim
{"title":"Discovery of natural inhibitors for osteoarthritis targeting inflammatory pathway with pharmacoinformatics and molecular docking","authors":"Rok Su Shim, Fahad Hassan Shah, Young Seok Eom, Saad Salman, Song Ja Kim","doi":"10.1007/s13596-024-00782-x","DOIUrl":null,"url":null,"abstract":"<div><p><i>Ziziphus jujuba</i> is a traditional Chinese medicinal plant, whose fruit (<i>Jujubae fructus</i>) has been highly utilized in herbal medicine for decades. The fruit of this plant contains a wide variety of phytochemicals having efficacious biological activity. These phytochemicals have been utilized in this study to discover potential drug candidates in preventing osteoarthritis (OA) progression using network pharmacology and molecular docking method. The phytochemicals information of <i>Jujubae fructus</i> was obtained from the TCMSP database, which were screened for druglikeness and oral bioavailability. Screened compounds were explored for Network pharmacology using BATMAN-TCM database and Molecular Docking with IGEMDOCK 2.1. Obtained compounds from this analysis were used to predict their ADMET properties. Network pharmacology analysis showed that Mairin, Oleanonic acid, Oleanolic acid, and Stigmasterol reduce inflammation and activate Peroxisome Proliferator-Activated Receptors (PPARs) signaling pathway to intervene with OA progression. Molecular docking predicted that Mairin, Oleanonic acid, and Stigmasterol reduce inflammation by targeting Janus-kinase-2 protein. All these compounds have moderate ADMET qualities, which need to be calibrated to counteract their toxic effect and increase the drug effectivity. Mairin, Oleanonic acid, and Stigmasterol are the potential phytochemicals of <i>Jujubae fructus</i> playing a therapeutic role in OA. These compounds can be further explored for invitro and clinical studies.</p></div>","PeriodicalId":7613,"journal":{"name":"Advances in Traditional Medicine","volume":"25 1","pages":"211 - 219"},"PeriodicalIF":1.8000,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Traditional Medicine","FirstCategoryId":"1085","ListUrlMain":"https://link.springer.com/article/10.1007/s13596-024-00782-x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Ziziphus jujuba is a traditional Chinese medicinal plant, whose fruit (Jujubae fructus) has been highly utilized in herbal medicine for decades. The fruit of this plant contains a wide variety of phytochemicals having efficacious biological activity. These phytochemicals have been utilized in this study to discover potential drug candidates in preventing osteoarthritis (OA) progression using network pharmacology and molecular docking method. The phytochemicals information of Jujubae fructus was obtained from the TCMSP database, which were screened for druglikeness and oral bioavailability. Screened compounds were explored for Network pharmacology using BATMAN-TCM database and Molecular Docking with IGEMDOCK 2.1. Obtained compounds from this analysis were used to predict their ADMET properties. Network pharmacology analysis showed that Mairin, Oleanonic acid, Oleanolic acid, and Stigmasterol reduce inflammation and activate Peroxisome Proliferator-Activated Receptors (PPARs) signaling pathway to intervene with OA progression. Molecular docking predicted that Mairin, Oleanonic acid, and Stigmasterol reduce inflammation by targeting Janus-kinase-2 protein. All these compounds have moderate ADMET qualities, which need to be calibrated to counteract their toxic effect and increase the drug effectivity. Mairin, Oleanonic acid, and Stigmasterol are the potential phytochemicals of Jujubae fructus playing a therapeutic role in OA. These compounds can be further explored for invitro and clinical studies.
期刊介绍:
Advances in Traditional Medicine (ADTM) is an international and peer-reviewed journal and publishes a variety of articles including original researches, reviews, short communications, and case-reports. ADTM aims to bridging the gap between Traditional knowledge and medical advances. The journal focuses on publishing valid, relevant, and rigorous experimental research and clinical applications of Traditidnal Medicine as well as medical classics. At the same time, the journal is devoted to communication among basic researcher and medical clinician interested in the advancement of Traditional Medicine. Topics covered by the journal are: Medical Classics & History; Biomedical Research; Pharmacology & Toxicology of Natural Products; Acupuncture & Moxibustion; Sasang Constitutional Medicine; Diagnostics and Instrumental Development; Clinical Research. ADTM is published four times yearly. The publication date of this journal is 30th March, June, September, and December.